000			01829nam a22002537a 4500
999			_c8243 _d8243
003			MED20100001
005			20240720152621.0
008			160505b2010 xxu||||| |||| 00| 0 eng d
040			_cFEU-NRMF MEDICAL LIBRARY
041			_aEnglish
050			_aMED20100001
100			_aAcosta, Charmaine D., MD.
245			_aBenzene associated aplastic anemia presenting 10 years after exposure case report / _cCharmaine D. Acosta.
260			_aFairview, Quezon City _bDepartment of Medicine, FEU-NRMF, _c2010
300			_c( in folder)
336			_atext _2rdacontent
337			_aunmediated _2rdamedia
338			_avolume _2rdacarrier
504			_aIncludes appendices and bibliographical references.
520			_aABSTRACT: Aplastic anemia is a syndrome characterized by reticulocytopenia, neutropenia, monocytopenia, and thrombocytopenia and replacement of the marrow with fat and a near absence of hematopoietic precursor cells. Most cases occur without an evident precipitating cause and result from expression of autoreactive T lymphocytes that suppress or destroy primitive hematopoietic cells while some cases are due to toxic effect of chemicals or drugs. Here I present a case of aplastic anemia that occured initially a decade after inciting agent has been removed. The case is E.I., 54-year old, male, Filipino who presented with easy fatigability that started 3 months prior to admission. Complete blood count revealed anemia, thrombocytopenia, and leukopenia. Peripheral blood smear showed paucity of blood cells with the bone marrow aspirate revealing hypocellularity. Patient underrwent blood transfusion of seven units of packed red blood cells. He was then discharged with modest improvement in the patient`s complete blood count.
521			_aRESDM
887			_aRES RC 0002
942			_2lcc _cRE